Nicaise Ndembi, MSc, PhD

Institute of Human Virology, Nigeria

Dr. Ndembi serves as the Director of Laboratory Research applying his wealth of experience in molecular virology to implement genomics capacity at the Institute of Human Virology Nigeria (IHVN). He is Adjunct Associate Professor, Division of Epidemiology and Prevention at the IHV, University of Maryland School of Medicine, US and Research Professor, Global Affairs Section, Kanazawa University, Japan.

Before that, Dr. Ndembi was head of the Virology Laboratory at the Uganda Virus Research Institute (MRC/UVRI and LSHTM Uganda Research Unit) where he supported several multi-country randomized controlled trials on HIV treatment strategy including the US Centers for Disease Control and Prevention (CDC) cluster-randomized trial to compare the effectiveness of home-based compared with facility-based delivery of antiretroviral therapy (Lancet 2009)  and the UK Medical Research Council DART trial (Lancet 2010).

Dr. Ndembi has served on several scientific advisory panels and continues to serve as an advisor on HIV drug resistance and control policy to Nigeria’s Federal Ministry of Health. He is a member of the PharmAccess Technical Advisory board for the Pan-African Study for Evaluation of Resistance (PASER) in Africa (Lancet Infectious Diseases 2012) and WHOResistance Network TWG (Lancet 2012).

Dr. Ndembi is a graduate of Kanazawa University School of Medicine, Department of Viral Infection and International Public Health. He is PI and co-investigator on numerous US National Health Institute (NIH) grants. He has authored/co-authored more than 130 publications in peer reviewed journals.

Dr. Ndembi main research interest includes HIV vaccine research especially understanding protective immune responses, genomics epidemiology, microbiome, Emerging and Re-Emerging Infectious Diseases, HIV diversity and resistance to Antiretroviral Therapy (ART).